We examined the association between vulnerability to financial exploitation and thickness of a brain region called the ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

Researchers are experimenting with memory-based activities as a way to treat Alzheimer's, saying it can boost cognitive neurons needed to fight the disease.

Pioneering musicians are trialling a radical approach that takes treatment beyond medicine – and could save the NHS millions ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...